AO
Atlas Oncology Holdings Inc.
SEC filingOther · Nashville, TN
Amount raised$23Msold at filing
Total offering$23M
Investors in the raise3count reported to the SEC
FiledFeb 25, 2026first sale Feb 10, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Matt Barnard KimDirector, Promoter
David Barnard GlaccumExecutive Officer, Director, Promoter
Ian Barnard ChiangDirector
Todd Barnard NiceExecutive Officer, Promoter
Kate Barnard RobertsExecutive Officer, Promoter
Tara Barnard SullivanDirector
Dave Barnard FieldingDirector, Promoter
Executive officers, directors and promoters as listed on the Form D.